Unlock stock picks and a broker-level newsfeed that powers Wall Street.
SES - Delayed Quote SGD

UG Healthcare Corporation Limited (8K7.SI)

Compare
0.1100
-0.0040
(-3.51%)
At close: April 4 at 5:04:03 PM GMT+8
Loading Chart for 8K7.SI
  • Previous Close 0.1140
  • Open 0.1180
  • Bid 0.1080 x --
  • Ask 0.1100 x --
  • Day's Range 0.1070 - 0.1180
  • 52 Week Range 0.0970 - 0.1590
  • Volume 231,400
  • Avg. Volume 108,391
  • Market Cap (intraday) 68.621M
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Nov 17, 2022
  • 1y Target Est --

UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. The company operates through Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products segments. It distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables. The company's products are used in various healthcare applications. It serves customers under the Unigloves brand name in Europe, North America, South America, Africa, Asia, and internationally. UG Healthcare Corporation Limited was founded in 1989 and is based in Singapore.

www.ughealthcarecorporation.com

898

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 8K7.SI

View More

Performance Overview: 8K7.SI

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is STI Index (^STI) .

YTD Return

8K7.SI
9.84%
STI Index (^STI)
1.01%

1-Year Return

8K7.SI
5.98%
STI Index (^STI)
18.26%

3-Year Return

8K7.SI
56.18%
STI Index (^STI)
11.97%

5-Year Return

8K7.SI
75.87%
STI Index (^STI)
60.13%

Compare To: 8K7.SI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 8K7.SI

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    68.62M

  • Enterprise Value

    91.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.50

  • Price/Book (mrq)

    0.42

  • Enterprise Value/Revenue

    0.66

  • Enterprise Value/EBITDA

    79.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.46%

  • Return on Assets (ttm)

    0.10%

  • Return on Equity (ttm)

    -2.93%

  • Revenue (ttm)

    138.17M

  • Net Income Avi to Common (ttm)

    -2.01M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.22M

  • Total Debt/Equity (mrq)

    27.91%

  • Levered Free Cash Flow (ttm)

    -14.49M

Research Analysis: 8K7.SI

View More

Company Insights: 8K7.SI

Research Reports: 8K7.SI

View More

People Also Watch